TGF-β and fibrosis in different organs — molecular pathway imprints
Tóm tắt
Từ khóa
Tài liệu tham khảo
Shi, 2003, Mechanisms of TGF-beta signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X
Faler, 2006, Transforming growth factor-beta and wound healing, Perspect. Vasc. Surg. Endovasc. Ther., 18, 55, 10.1177/153100350601800123
Hocevar, 2000, Analysis of TGF-beta-mediated synthesis of extracellular matrix components, Methods Mol. Biol., 142, 55
Wahl, 2005, Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases, Arthritis Res. Ther., 7, 62, 10.1186/ar1504
Sato, 1989, Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture, J. Cell Biol., 109, 309, 10.1083/jcb.109.1.309
Yu, 2000, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis, Genes Dev., 14, 163, 10.1101/gad.14.2.163
Munger, 1999, The integrin alpha V beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis, Cell, 96, 319, 10.1016/S0092-8674(00)80545-0
Mu, 2002, The integrin alpha(V)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1, J. Cell Biol., 157, 493, 10.1083/jcb.200109100
Wipff, 2008, Integrins and the activation of latent transforming growth factor beta1 — an intimate relationship, Eur. J. Cell Biol., 87, 601, 10.1016/j.ejcb.2008.01.012
Lyons, 1988, Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium, J. Cell Biol., 106, 1659, 10.1083/jcb.106.5.1659
Murphy-Ullrich, 2000, Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology, Cytokine Growth Factor Rev., 11, 59, 10.1016/S1359-6101(99)00029-5
Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-beta family signalling, Nature, 425, 577, 10.1038/nature02006
Chen, 2004, Syndecan-2 regulates transforming growth factor-beta signaling, J. Biol. Chem., 279, 15715, 10.1074/jbc.C300430200
You, 2007, The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation, Carcinogenesis, 28, 2491, 10.1093/carcin/bgm195
Massague, 2000, How cells read TGF-beta signals, Nat. Rev., Mol. Cell Biol., 1, 169, 10.1038/35043051
Wotton, 2001, Smad transcriptional corepressors in TGF beta family signaling, Curr. Top. Microbiol. Immunol., 254, 145
Massague, 2003, Integration of Smad and MAPK pathways: a link and a linker revisited, Genes Dev., 17, 2993, 10.1101/gad.1167003
Yakymovych, 2001, Regulation of Smad signaling by protein kinase C, FASEB J., 15, 553, 10.1096/fj.00-0474fje
Conery, 2004, Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis, Nat. Cell Biol., 6, 366, 10.1038/ncb1117
Masszi, 2003, Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial–mesenchymal transition, Am. J. Physiol. Renal Physiol., 284, F911, 10.1152/ajprenal.00183.2002
Muller, 2002, Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells, Oncogene, 21, 6049, 10.1038/sj.onc.1205766
Wang, 2004, Transforming growth factor beta regulates cell–cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells, Oncogene, 23, 5558, 10.1038/sj.onc.1207701
Thannickal, 2003, Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase, J. Biol. Chem., 278, 12384, 10.1074/jbc.M208544200
Shi-Wen, 2009, Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts, Arthritis Rheum., 60, 234, 10.1002/art.24223
Liu, 2007, FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype, Mol. Biol. Cell, 18, 2169, 10.1091/mbc.E06-12-1121
Hayashi, 1997, The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling, Cell, 89, 1165, 10.1016/S0092-8674(00)80303-7
Nakao, 1997, Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling, Nature, 389, 631, 10.1038/39369
Salvador, 2006, Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis, Rheumatology. (Oxford), 45, 966, 10.1093/rheumatology/kel043
Kim, 2004, TGF-beta1 polymorphism determines the progression of joint damage in rheumatoid arthritis, Scand. J. Rheumatol., 33, 389, 10.1080/03009740410010344
Cheon, 2002, Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals, Clin. Exp. Immunol., 127, 547, 10.1046/j.1365-2249.2002.01785.x
Yamanishi, 2002, Expression and regulation of aggrecanase in arthritis: the role of TGF-beta, J. Immunol., 168, 1405, 10.4049/jimmunol.168.3.1405
Hamilton, 1991, Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts, Proc. Natl. Acad. Sci. U. S. A., 88, 7180, 10.1073/pnas.88.16.7180
Taketazu, 1994, Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis, Lab. Invest., 70, 620
Chu, 1991, Transforming growth factor-beta 1 in rheumatoid synovial membrane and cartilage/pannus junction, Clin. Exp. Immunol., 86, 380, 10.1111/j.1365-2249.1991.tb02941.x
Szekanecz, 1995, Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease, Clin. Immunol. Immunopathol., 76, 187, 10.1006/clin.1995.1114
Goddard, 1992, Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cells, Arthritis Rheum., 35, 1296, 10.1002/art.1780351109
Fava, 1989, Active and latent forms of transforming growth factor beta activity in synovial effusions, J. Exp. Med., 169, 291, 10.1084/jem.169.1.291
Pohlers, 2007, Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts, Arthritis Res. Ther., 9, R59, 10.1186/ar2217
Müssener, 1997, Dynamic expression of transforming growth factor-betas (TGF-beta) and their type I and type II receptors in the synovial tissue of arthritic rats, Clin. Exp. Immunol., 107, 112, 10.1046/j.1365-2249.1997.d01-896.x
Allen, 1990, Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta, J. Exp. Med., 171, 231, 10.1084/jem.171.1.231
Wahl, 1993, Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta, J. Exp. Med., 177, 225, 10.1084/jem.177.1.225
Mi, 2003, Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees, Arthritis Res. Ther., 5, R132, 10.1186/ar745
Sakuma, 2007, TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody, Int. Immunol., 19, 117, 10.1093/intimm/dxl128
Brandes, 1991, Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals, J. Clin. Invest., 87, 1108, 10.1172/JCI115073
Schramm, 2004, Susceptibility to collagen-induced arthritis is modulated by TGFbeta responsiveness of T cells, Arthritis Res. Ther., 6, R114, 10.1186/ar1039
Chernajovsky, 1997, Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model, Gene Ther., 4, 553, 10.1038/sj.gt.3300436
Ziyadeh, 1994, Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta, J. Clin. Invest., 93, 536, 10.1172/JCI117004
Ziyadeh, 1998, Evidence for the involvement of transforming growth factor-β in the pathogenesis of diabetic kidney disease: are Koch's postulates fulfilled?, Curr. Pract. Med., 1, 87
Wolf, 1992, High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta, Kidney Int., 42, 647, 10.1038/ki.1992.330
Wolf, 1993, Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta, J. Clin. Invest., 92, 1366, 10.1172/JCI116710
Yamamoto, 1993, Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy, Proc. Natl. Acad Sci. U. S. A, 90, 1814, 10.1073/pnas.90.5.1814
Sharma, 1994, Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse, Am. J. Physiol., 267, F1094
Hong, 2001, Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse, Am. J. Pathol., 158, 1653, 10.1016/S0002-9440(10)64121-1
Sharma, 1996, Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice, Diabetes, 45, 522, 10.2337/diab.45.4.522
Ziyadeh, 2000, Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice, Proc. Natl. Acad Sci. U. S. A., 97, 8015, 10.1073/pnas.120055097
Isono, 2000, Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney, Am. J. Physiol., Renal Physiol., 278, F830, 10.1152/ajprenal.2000.278.5.F830
Wolf, 1996, Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells, Nephrol. Dial. Transplant., 11, 263, 10.1093/oxfordjournals.ndt.a027251
Han, 2000, Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice, Am. J. Physiol., Renal Physiol., 278, F628, 10.1152/ajprenal.2000.278.4.F628
Abbate, 2002, Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis, Am. J. Pathol., 161, 2179, 10.1016/S0002-9440(10)64495-1
Gilbert, 1998, Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition, Diabetes, 47, 414, 10.2337/diabetes.47.3.414
Wolf, 2005, From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy, Diabetes, 54, 1626, 10.2337/diabetes.54.6.1626
Wu, 2005, TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes, J. Am. Soc. Nephrol., 16, 3211, 10.1681/ASN.2004121055
Dallas, 1995, Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein, J. Cell Biol., 131, 539, 10.1083/jcb.131.2.539
Isono, 2002, Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells, Biochem. Biophys. Res. Commun., 296, 1356, 10.1016/S0006-291X(02)02084-3
Furuse, 2004, Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats, Nephron, Exp. Nephrol., 98, e100, 10.1159/000080685
Schiffer, 2002, Inhibitory smads and tgf-Beta signaling in glomerular cells, J. Am. Soc. Nephrol., 13, 2657, 10.1097/01.ASN.0000033276.06451.50
Cordenonsi, 2007, Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation, Science, 315, 840, 10.1126/science.1135961
Schiffer, 2004, A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis, J. Biol. Chem., 279, 37004, 10.1074/jbc.M403534200
Yoshioka, 1993, Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys, Lab. Invest., 68, 154
Yamamoto, 1996, Expression of transforming growth factor-beta isoforms in human glomerular diseases, Kidney Int., 49, 461, 10.1038/ki.1996.65
Sharma, 1997, Increased renal production of transforming growth factor-beta1 in patients with type II diabetes, Diabetes, 46, 854, 10.2337/diab.46.5.854
Tsakas, 2006, Accurate measurement and clinical significance of urinary transforming growth factor-beta1, Am. J. Nephrol., 26, 186, 10.1159/000093178
Sharma, 1999, Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients, Am. J. Kidney Dis., 34, 818, 10.1016/S0272-6386(99)70037-5
Babyatsky, 1996, Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease, Gastroenterology, 110, 975, 10.1053/gast.1996.v110.pm8613031
Blobe, 2000, Role of transforming growth factor beta in human disease, N. Engl. J. Med., 342, 1350, 10.1056/NEJM200005043421807
Izcue, 2006, Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation, Immunol. Rev., 212, 256, 10.1111/j.0105-2896.2006.00423.x
Gorelik, 2002, Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation, J. Exp. Med., 195, 1499, 10.1084/jem.20012076
Kulkarni, 1993, Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death, Proc. Natl. Acad. Sci. U. S. A, 90, 770, 10.1073/pnas.90.2.770
Boirivant, 1998, Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4, J. Exp. Med., 188, 1929, 10.1084/jem.188.10.1929
Neurath, 1996, Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice, Nat. Med., 2, 998, 10.1038/nm0996-998
Powrie, 1996, A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells, J. Exp. Med., 183, 2669, 10.1084/jem.183.6.2669
Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753
Mangan, 2006, Transforming growth factor-beta induces development of the T(H)17 lineage, Nature, 441, 231, 10.1038/nature04754
Veldhoen, 2006, TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, 24, 179, 10.1016/j.immuni.2006.01.001
Santarlasci, 2009, TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells, Eur. J. Immunol., 39, 207, 10.1002/eji.200838748
Volpe, 2008, A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses, Nat. Immunol., 9, 650, 10.1038/ni.1613
Yang, 2008, IL-21 and TGF-beta are required for differentiation of human T(H)17 cells, Nature, 454, 350, 10.1038/nature07021
Yang, 1999, Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta, EMBO J., 18, 1280, 10.1093/emboj/18.5.1280
Monteleone, 2001, Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease, J. Clin. Invest., 108, 601, 10.1172/JCI12821
Bhowmick, 2001, Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism, Mol. Biol. Cell, 12, 27, 10.1091/mbc.12.1.27
Ellenrieder, 2001, Transforming growth factor beta1 treatment leads to an epithelial–mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation, Cancer Res., 61, 4222
Fujimoto, 2001, Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells, Exp. Cell Res., 266, 239, 10.1006/excr.2000.5229
Lehmann, 2000, Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells, Genes Dev., 14, 2610, 10.1101/gad.181700
Oft, 1998, TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis, Curr. Biol., 8, 1243, 10.1016/S0960-9822(07)00533-7
Portella, 1998, Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion, Cell Growth Differ., 9, 393
Arias, 2001, Epithelial mesenchymal interactions in cancer and development, Cell, 105, 425, 10.1016/S0092-8674(01)00365-8
Thiery, 1999, Epithelial cell plasticity in development and tumor progression, Cancer Metastasis Rev., 18, 31, 10.1023/A:1006256219004
Kalluri, 2003, Epithelial–mesenchymal transition and its implications for fibrosis, J. Clin. Invest, 112, 1776, 10.1172/JCI200320530
Saika, 2004, Smad3 signaling is required for epithelial–mesenchymal transition of lens epithelium after injury, Am. J. Pathol., 164, 651, 10.1016/S0002-9440(10)63153-7
Sato, 2003, Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, J. Clin. Invest, 112, 1486, 10.1172/JCI200319270
Beck, 1999, Growth factors in inflammatory bowel disease, Inflamm. Bowel Dis., 5, 44, 10.1097/00054725-199902000-00007
Fiocchi, 2001, TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation, J. Clin. Invest, 108, 523, 10.1172/JCI13863
Hahm, 2001, Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease, Gut, 49, 190, 10.1136/gut.49.2.190
Matthes, 1992, Cellular localization of procollagen gene transcripts in inflammatory bowel diseases, Gastroenterology, 102, 431, 10.1016/0016-5085(92)90087-F
Stallmach, 1992, Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease, Gastroenterology, 102, 1920, 10.1016/0016-5085(92)90314-O
Lawrance, 2001, Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine, Inflamm. Bowel. Dis., 7, 16, 10.1097/00054725-200102000-00003
Pucilowska, 2000, Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models, Am. J. Physiol.: Gasterointest. Liver Physiol., 279, G653
Liem, 1999, Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease, Transplantation, 67, 59, 10.1097/00007890-199901150-00009
Stahle-Backdahl, 2000, Increased presence of eosinophilic granulocytes expressing transforming growth factor-beta1 in collagenous colitis, Scand. J. Gastroenterol., 35, 742, 10.1080/003655200750023426
Wang, 1998, Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy, Am. J. Pathol., 153, 1531, 10.1016/S0002-9440(10)65741-0
di Mola, 1999, Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease, Ann. Surg., 229, 67, 10.1097/00000658-199901000-00009
McKaig, 2002, Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts, Am. J. Physiol., Cell Physiol., 282, C172, 10.1152/ajpcell.00048.2001
Monteleone, 2005, Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease, Gastroenterology, 129, 1420, 10.1053/j.gastro.2005.09.005
Monteleone, 2004, Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection, Gastroenterology, 126, 674, 10.1053/j.gastro.2003.11.048
Randall, 1995, Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage, Int. J. Radiat. Biol., 68, 301, 10.1080/09553009514551231
Randall, 1996, Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation, Int. J. Radiat. Biol., 70, 351, 10.1080/095530096145085
Martin, 1993, Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation, Radiat. Res., 134, 63, 10.2307/3578502
Martin, 2000, TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?, Int. J. Radiat. Oncol. Biol. Phys., 47, 277, 10.1016/S0360-3016(00)00435-1
Schultze-Mosgau, 2002, Transforming growth factor beta1 and beta2 (TGFbeta2/TGFbeta2) profile changes in previously irradiated free flap beds, Head Neck, 24, 33, 10.1002/hed.10011
Schultze-Mosgau, 2003, Transforming growth factor-beta receptor-II up-regulation during wound healing in previously irradiated graft beds in vivo, Wound Repair Regen., 11, 297, 10.1046/j.1524-475X.2003.11410.x
Schultze-Mosgau, 2004, Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1 (TGFbeta1)-treatment in irradiated rat tissue, Radiother. Oncol., 70, 249, 10.1016/j.radonc.2004.01.010
Border, 1994, Transforming growth factor beta in tissue fibrosis, N. Engl. J. Med., 331, 1286, 10.1056/NEJM199411103311907
Schultze-Mosgau, 2006, Plasminogen activator inhibitor-I-related regulation of procollagen I (alpha1 and alpha2) by antitransforming growth factor-beta1 treatment during radiation-impaired wound healing, Int. J. Radiat. Oncol. Biol. Phys., 64, 280, 10.1016/j.ijrobp.2005.09.006
Ulrich, 2004, Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants, Plast. Reconstr. Surg., 114, 229, 10.1097/01.PRS.0000129079.19089.6C
Schiro, 1991, Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells, Cell, 67, 403, 10.1016/0092-8674(91)90191-Z
Arora, 1999, The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts, Am. J. Pathol., 154, 871, 10.1016/S0002-9440(10)65334-5
Tibbs, 1997, Wound healing following radiation therapy: a review, Radiother. Oncol., 42, 99, 10.1016/S0167-8140(96)01880-4
Tokarek, 1994, Effect of therapeutic radiation on wound healing, Clin. Dermatol., 12, 57, 10.1016/0738-081X(94)90257-7
Schultze-Mosgau, 2002, Vascularization in the transition area between free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region, Head Neck, 24, 42, 10.1002/hed.10012
Li, 1999, TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis, Int. J. Cancer, 84, 155, 10.1002/(SICI)1097-0215(19990420)84:2<155::AID-IJC11>3.0.CO;2-S
Rey, 2001, Detection of enteroviruses ribonucleic acid sequences in endomyocardial tissue from adult patients with chronic dilated cardiomyopathy by a rapid RT-PCR and hybridization assay, J. Med. Virol., 64, 133, 10.1002/jmv.1028
Melnik, 1996, Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, 655
Rose, 1992, Coxsackievirus myocarditis, 411
Maisch, 2006, [Myocardial fibrosis: a cardiopathophysiologic Janus head], Herz, 31, 260, 10.1007/s00059-006-2823-9
Eismann, 2002, Fibronectin splice variants—prognostic markers for the stage of renal interstitial fibrosis in the rat, Nephron, 92, 379, 10.1159/000063314
Tamura, 1996, Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions, Heart, 75, 291, 10.1136/hrt.75.3.291
Rosenkranz, 2002, Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1), Am. J. Physiol. Heart Circ. Physiol., 283, H1253, 10.1152/ajpheart.00578.2001
Isoda, 2001, Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha, J. Card. Fail., 7, 355, 10.1054/jcaf.2001.28221
Bryant, 1998, Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha, Circulation, 97, 1375, 10.1161/01.CIR.97.14.1375
Kubota, 1997, Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice, J. Card. Fail., 3, 117, 10.1016/S1071-9164(97)90045-2
Ponten, 2003, Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy, Am. J. Pathol., 163, 673, 10.1016/S0002-9440(10)63694-2
Ponten, 2005, Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice, Circ. Res., 97, 1036, 10.1161/01.RES.0000190590.31545.d4
Gluck, 2001, Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice, J. Mol. Cell Cardiol., 33, 1615, 10.1006/jmcc.2001.1416
Schmidtke, 2000, Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis, J. Med. Virol., 61, 518, 10.1002/1096-9071(200008)61:4<518::AID-JMV16>3.0.CO;2-F
Shioi, 1996, Persistent expression of cytokine in the chronic stage of viral myocarditis in mice, Circulation, 94, 2930, 10.1161/01.CIR.94.11.2930
Satoh, 1996, Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy, Virchows Arch., 427, 503, 10.1007/BF00199511
Sakata, 2008, Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor, Basic Res. Cardiol., 103, 60, 10.1007/s00395-007-0689-5
Heldin, 2002, New members of the platelet-derived growth factor family of mitogens, Arch. Biochem. Biophys., 398, 284, 10.1006/abbi.2001.2707
Grun, 2005, Elevated expression of PDGF-C in coxsackievirus B3-induced chronic myocarditis, Eur. Heart J., 26, 728, 10.1093/eurheartj/ehi168
Wessely, 2001, Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication, Circulation, 103, 756, 10.1161/01.CIR.103.5.756
Leipner, 2008, Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis, Cardiovasc. Res., 79, 118, 10.1093/cvr/cvn063
Neef, 2006, Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term, J. Hepatol., 44, 167, 10.1016/j.jhep.2005.06.015
Paniagua, 2006, Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis, J. Clin. Invest., 116, 2633, 10.1172/JCI28546.
Wang, 2005, Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo, FASEB J., 19, 1, 10.1096/fj.04-2370com
Aono, 2005, Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice, Am. J. Respir. Crit. Care Med., 171, 1279, 10.1164/rccm.200404-531OC
Wilkes, 2005, Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2, Cancer Res., 65, 10431, 10.1158/0008-5472.CAN-05-1522
Daniels, 2004, Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis, J. Clin. Invest., 114, 1308, 10.1172/JCI200419603
Plattner, 1999, c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF, Genes Dev., 13, 2400, 10.1101/gad.13.18.2400
Seeland, 2002, Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase, Eur. J. Clin. Invest., 32, 295, 10.1046/j.1365-2362.2002.00985.x
Xiao, 2008, Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models, Clin. Exp. Pharmacol. Physiol., 35, 335, 10.1111/j.1440-1681.2007.04876.x
Gordon, 2008, Role of transforming growth factor-beta superfamily signaling pathways in human disease, Biochim. Biophys. Acta, 1782, 197, 10.1016/j.bbadis.2008.01.006
Mead, 2003, Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery, Invest. Ophthalmol. Vis. Sci., 44, 3394, 10.1167/iovs.02-0978
Denton, 2007, Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192, Arthritis Rheum., 56, 323, 10.1002/art.22289
[http://clinicaltrials.gov/ct2/show/NCT00125385].
[http://clinicaltrials.gov/ct2/show/NCT00464321].
[http://clinicaltrials.gov/ct2/show/NCT00356460].
Juarez, 2007, Soluble betaglycan reduces renal damage progression in db/db mice, Am. J. Physiol. Renal. Physiol., 292, F321, 10.1152/ajprenal.00264.2006
Rowland-Goldsmith, 2002, Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis, Mol. Cancer Ther., 1, 161
Muraoka, 2002, Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases, J. Clin. Invest., 109, 1551, 10.1172/JCI0215234
Hau, 2007, Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies, Oligonucleotides, 17, 201, 10.1089/oli.2006.0053
Nemunaitis, 2006, Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer, J. Clin. Oncol., 24, 4721, 10.1200/JCO.2005.05.5335
Suzuki, 2007, A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection, Cancer Res., 67, 2351, 10.1158/0008-5472.CAN-06-2389
Frangogiannis, 2005, Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts, Circulation, 111, 2935, 10.1161/CIRCULATIONAHA.104.510354
Chuva de Sousa Lopes, 2004, Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction, Dev. Dyn., 231, 542, 10.1002/dvdy.20162
Gotis-Graham, 1997, Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium, Arthritis Rheum., 40, 1780, 10.1002/art.1780401009
Wu, 2007, Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis, Inflamm. Bowel Dis., 13, 807, 10.1002/ibd.20110
Wahab, 2005, Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli, Diabetologia, 48, 2650, 10.1007/s00125-005-0006-5
Brennan, 1990, Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures, Clin. Exp. Immunol., 81, 278, 10.1111/j.1365-2249.1990.tb03331.x
Hao, 1999, Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing, J. Mol. Cell Cardiol., 31, 667, 10.1006/jmcc.1998.0902
Waltenberger, 1993, Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease, Am. J. Pathol, 142, 71
Klahr, 1999, Mechanisms of progression of chronic renal damage, J. Nephrol., 12, S53